Profile
Phillip Samayoa is the founder of Dyne Therapeutics, Inc. (2017) and Codiak BioSciences, Inc. (2014).
Dr. Samayoa is currently the Chief Scientific Officer at Generation Bio Co. since 2025.
Former jobs include Director at Merck Research Ventures Fund, Principal at Merck & Co., Inc. (2016), Principal at Atlas Venture Advisors, Inc. (2016-2018), Associate at Flagship Pioneering, Inc., Principal at Bayer Technology Services GmbH, Principal at Infinity Pharmaceuticals, Inc., and Principal at Decision Resources, Inc. Education includes an undergraduate degree from the Massachusetts Institute of Technology (2009) and a doctorate from the University of California San Diego (2012).
Phillip Samayoa active positions
| Companies | Position | Start |
|---|---|---|
| GENERATION BIO CO. | Chief Tech/Sci/R&D Officer | 10/01/2025 |
Former positions of Phillip Samayoa
| Companies | Position | End |
|---|---|---|
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Private Equity Investor | 31/01/2018 |
| DYNE THERAPEUTICS, INC. | Founder | 01/01/2018 |
| MERCK & CO., INC. | Corporate Officer/Principal | 30/06/2016 |
| CODIAK BIOSCIENCES | Founder | 31/03/2015 |
Merck Research Ventures Fund
Merck Research Ventures Fund Investment ManagersFinance Acts as Venture Capital Fund | Director/Board Member | - |
Training of Phillip Samayoa
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
Bayer Technology Services GmbH
Bayer Technology Services GmbH Engineering & ConstructionIndustrial Services Provides plant process, development and engineering solutions | Industrial Services |
Infinity Pharmaceuticals, Inc.
Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
Decision Resources, Inc.
Decision Resources, Inc. Investment ManagersFinance Provides investment research | Finance |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Ventures Fund
Merck Research Ventures Fund Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Codiak BioSciences, Inc.
Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops exosome based therapeutics | Health Technology |
Generation Bio Co.
Generation Bio Co. Pharmaceuticals: MajorHealth Technology Develops and commercializes genetic medicines | Health Technology |
Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat muscle diseases | Health Technology |
- Stock Market
- Insiders
- Phillip Samayoa
















